http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022129097-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9af4862fb709235a3ffd4e65934db71d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
| filingDate | 2021-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1855fe2688e715b2c5944015d9a52117 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1421fe3d1ea2ee3a5c4709111296324 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7819d7777fb6dcc4119866e6212cfc81 |
| publicationDate | 2022-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2022129097-A2 |
| titleOfInvention | Sirna and compositions for prophylactic and therapeutic treatment of virus diseases |
| abstract | The invention relates to siRNA molecules and compositions which modulate the expression of the Eukaryotic Translation Elongation Factor 1 Alpha 2 (EEF1A2) gene, which can be useful in reducing viral replication and managing viral infections or infestations. Such molecules and compositions can be useful in treating or preventing infection with RNA viruses in humans (for example, coronaviruses such as SARS-CoV-2 or influenza viruses such as influenza virus type A) or in agriculturally important plants. |
| priorityDate | 2020-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1825.